activity as a tumor initiator, however, derivatives with The present study has analysed the DNA adducts formed in methyl substituents at positions 7-, 12-or both are SENCAR mouse epidermis following topical application of considerably more active (4) . Of the 12 possible monomethyl-
7-methylbenz[a]anthracene (7-MBA). Mice were treated
benz [a] anthracenes, 7-methylbenz[a]anthracene (7-MBA) is with 400 nmol of 7-MBA, which represents an initiating dose the most potent carcinogen for mouse skin, as well as other of this hydrocarbon for SENCAR mice. DNA adducts were tissues (4) (5) (6) (7) (8) , and the dimethyl derivative, 7,12-dimethylanalysed 24 h after topical application of the hydrocarbon benz [a] anthracene (DMBA) is one of the most potent skin by 32 P-postlabeling coupled with either HPLC analysis or an carcinogens known (4) . improved TLC procedure giving better resolution of DNA Structural characterization of the DNA adducts formed adducts through the use of a D6 solvent [isopropanol: 4N following in vitro reaction of (Ϯ) anti-DMBA-diol-epoxide NH 4 OH (1:1)] following D5. Twenty-four hours after topical (anti-DMBADE) with calf thymus DNA showed similar extents application of 400 nmol 7-MBA, the level of total covalent of reaction of the (Ϯ) anti-DMBADE with both deoxyguanobinding was 0.37 Ϯ 0.07 pmol/mg DNA as determined by sine (dGuo) and deoxyadenosine (dAdo) residues (9) . In 32 P-postlabeling. This level of binding correlated well with contrast, reaction of (Ϯ) anti-7-MBADE with calf thymus the relative tumor initiating activity of this hydrocarbon DNA showed that, while this DE binds to both dGuo and compared to 7,12-dimethylbenz[a]anthracene (6.4 Ϯ 0.01 dAdo residues, the extent of reaction with dGuo was significpmol/mg DNA) and dibenz[a,j]anthracene (0.03 Ϯ 0.01 pmol/ antly higher (9, 10) . This preference of the (Ϯ) anti-7-MBADE mg DNA). Analysis of the 32 P-labeled 3Ј,5Ј-diphosphodeoxyfor binding to dGuo residues is more similar to that of ribonucleosides by HPLC and TLC revealed the presence of
the (Ϯ) anti-benzo[a]pyrene-diol-epoxide [(Ϯ)-anti-BPDE] (4) deoxyguanosine (dGuo) and deoxyadenosine (dAdo) adducts
than that of (Ϯ) anti-DMBADE. Recent studies have shown formed from both the anti-and syn-bay-region diol-epoxides that the highly mutagenic syn-diol-epoxide derivatives of of 7-MBA (anti-and syn-7-MBADEs). The major DNA benzo[c]phenanthrene (B[c]Ph) and benzo[g]chrysene show adduct derived from 7-MBA in mouse epidermis was tentatpreferential formation of dAdo adducts, accounting for 80-ively identified as (ϩ) anti-7-MBADE-trans-N 2 -dGuo. In 90% of the total adducts formed following reaction of these addition, a minor dGuo adduct derived from the bay-region diol-epoxides with calf thymus DNA in vitro (11) . Other PAH syn-diol-epoxide of 7-MBA was detected as well as a minor diol-epoxides such as the (Ϯ) anti-and syn-diol-epoxides of dAdo adduct from this diol-epoxide. Another minor dAdo dibenz[a,j]-anthracene (DB[a,j]A) also bind to dAdo residues adduct was also detectably present which arose from either upon reaction with calf thymus DNA in vitro, however, both the anti-or syn-diol epoxide. Furthermore, several unidentiof these bay-region diol-epoxides bind more extensively to fied DNA adducts were present in both HPLC and TLC dGuo residues in reactions with calf thymus DNA in vitro chromatograms of DNA samples from 7-MBA-treated mice. (12) (13) (14) . These results are discussed in terms of the role of specific 7-Considerable evidence now suggests that binding to dAdo MBA-DNA adducts in tumor initiation by this hydrocarbon.
residues in DNA might be critical for the tumor initiating activity of some PAH (4, (15) (16) (17) , including those discussed above. Adducts with dAdo have been identified in DNA from in the supF gene from this plasmid in human cells consistent with this preference (19) . Thus, the current data with 7-MBA and its bay-region anti-diol-epoxide are very similar to our recent findings with DB[a,j]A and its bay-region anti-diolepoxide where Ha-ras mutations found in tumors induced by this PAH do not match the preference for binding to dGuo (20) and a mutational spectrum dominated by mutations at dGuo residues (21) .
In the present study, we have examined the major DNA adducts formed in mouse epidermis 24 h after topical application of 7-MBA using 32 P-postlabeling coupled with HPLC and TLC. Although minor dAdo adducts derived from both antiand syn-7-MBADEs were tentatively identified, the major DNA adduct formed in mouse epidermis in vivo was tentatively identified as (ϩ) anti-7-MBADE-trans-dGuo. In addition, several unidentified DNA adducts were also detectably present. The results are discussed in relation to the tumor initiating activity of 7-MBA and the spectrum of mutations observed in c-Ha-ras in mouse skin tumors initiated with this PAH.
Materials and methods
Chemicals 7-MBA was provided by Sigma-Aldrich Library of Rare Chemicals (Milwaukee, WI). (Ϯ) Anti 7-MBADE was prepared as previously described (10) . The synthesis of (Ϯ) syn-7-MBA will be described elsewhere. RNase A (EC 3.1. 7-MBADE or (Ϯ) syn-7-MBADE was enzymatically digested and adducts Macherey-Nagel polyethyleneimine (PEI)-cellulose thin-layer chromatography were enriched using the same procedures described in the preceding paragraph. (TLC) plates were obtained from Bodman (Aston, PA). A Zorbax phenylThe 3Ј-nucleoide monophosphates were again converted to 3Ј,5Ј-deoxyribomodified reverse-phase high performance liquid chromatography (HPLC) nucleosidediphosphates in reaction with cold ATP (2 mM) and T4 PNK column was obtained from Mac-Mod Analytical, Inc. (Chadds Ford, PA).
(40 units).
DNA adduct formation in vivo
HPLC analysis of 7-MBA-DNA adducts Female SENCAR mice aged 7-9 weeks (three or four animals per group)
Prior to HPLC analyses, 32 P-labeled DNA digests were subjected to onewere treated by topical application to the shaved dorsal skin with 400 nmol dimensional PEI-cellulose TLC to remove excess [γ-32 P]ATP and other of 7-MB[a]A. Animals were killed 24 h after treatment. DNA was isolated cofactors. Labeled mixtures were spotted on PEI-cellulose TLC plates (10ϫ15 from epidermis using guanidine isothiocyanate and then successive phenol cm) with a paper wick attached and developed overnight with 1.7 M sodium and chloroform/isoamyl alcohol extractions followed by treatment with RNase phosphate buffer, pH 5.8. PEI-cellulose at the origin was scraped off and A as described previously (17) .
extracted four times with 0.5 ml of 4 M pyridinium formate buffer (pH 4.5).
DNA adduct synthesis in vitro
Pyridinium formate extracts were combined and evaporated to dryness in a For DNA adduct synthesis in vitro, unlabeled calf thymus DNA or calf thymus Speed-Vac. Residues were redissolved in 100 µl of 50% methanol in water. DNA labeled with [ 3 H]dGuo or [ 3 H]dAdo was used ( Figure 1 ). Labeled DNA HPLC analyses of hydrocarbon modified 32 P-post-labeled 3Ј,5Ј-diphosphowas prepared by using a slight modification as previously described (12) of deoxyribonucleosides were carried out using a Shimadzu LC6A Liquid the method supplied with the nick translation kit from Bethesda Research Chromatograph equipped with a UV detector (254 nm) and a Packard Laboratories, Gaithersburg, MD. For DNA adduct synthesis 3 H-labeled DNA Radiomatic 500TR flow scintillation analyser. Separations were performed on (13 µg) was diluted with unlabeled DNA (400 µg). Unlabeled and 3 H-labeled a Zorbax SB-phenyl reverse-phase column (4.6 mmϫ25 cm) with the following calf thymus DNAs were reacted with (Ϯ) anti-7-MBADE or (Ϯ) syn-7-solvent system: 0-40 min, a linear gradient of 10-43% B (methanol) in buffer MBADE (100 µl of a 1 mg/ml solution in acetone) in 0.01 M Tris buffer A (0.5 M sodium phosphate buffer pH 3.0); 40-90 min, a linear gradient of (1.5 ml, pH 7.0) at 37°C for 16 h. DNA was precipitated by addition of ice-43-45% B in buffer A; 90-120 min, isocratic at 45% B in buffer A; 120-cold ethanol (2 volumes) and 7.5 M sodium acetate (1/2 volume), and then 140 min, a linear gradient of 45-60% B in buffer A; 140-155 min, a linear washed sequentially with ethanol, HPLC-grade acetone and anhydrous ether.
gradient of 60-100% B in buffer A. The flow rate was 0.8 ml/min. An anti-7-MBA tetraol which eluted in the shallow part of the gradient was used as 32 P-postlabeling analysis an internal UV marker. DNA adduct levels were estimated as described DNA samples (50 µg) were hydrolyzed to 3Ј-nucleoide monophosphates previously (17) . Adduct-associated radioactivity was calculated after subessentially as described (17) . Briefly, samples were incubated with micrococcal tracting background, taking into account the fraction of the total sample nuclease (80 mU/µg DNA) in 3 mM N,N-bis(2-hydroxyethyl)glycine (bicine, injected and decay of radiolabel from the time of postlabeling. AdductpH 9.0) and 0.5 mM CaCl 2 . After 2 h at 37°C, 23 µl of 20 mM sodium associated radioactivity was converted to a molar equivalent amount of adduct, acetate (pH 5.0) and spleen phosphodiesterase (1.6 U/µg DNA) were added, assuming only one 32 P-labeled phosphate group per adduct molecule, and and samples were incubated at 37°C for another 2 h. Adducts were extracted binding levels were expressed as pmol or fmol of adduct per mg of from the resulting hydrolysate (equivalent to 30 µg of DNA) by a slight epidermal DNA. modification of the n-butanol enrichment protocol (17) . Following extraction TLC-analysis of 32 P-postlabeled DNA adducts and evaporation to dryness in a Speed-Vac, adduct residues were reconstituted in 15.3 µl of water and 3.2 µl of labeling buffer (100 mM bicine-NaOH, pH
Resolution of 32 P-labeled adducts was carried out on commercial PEI cellulose TLC sheets. The solvents used for development were as described by Reddy 7.6; 100 mM MgCl 2 ; 100 mM dithiothreitol; 10 mM spermidine). Two microliters of 3Ј-phosphatase-free T4 polynucleotide kinase and 12. , and was in the same direction as D3. Note that previous studies had used a similar solvent system, but chromatography in these studies was in the D4 or D5 direction (23, 24) . Spots of radioactivity on developed chromatograms were located by autoradiography with intensifying screens.
Results

Preparation and analysis of (Ϯ) anti-and (Ϯ) syn-7-MBADE DNA adduct markers
In the present study, the analysis of DNA adducts formed in mouse epidermis was performed by the 32 P-post-labeling technique coupled with HPLC or TLC analysis. In order to tentatively identify the DNA adducts formed, we prepared marker DNA adducts from (Ϯ) anti-and (Ϯ) syn-7-MBADEs. Using the scheme shown in Figure 1, Figure 2 (panel A). Following reaction of (Ϯ) anti-7-MBADE with calf thymus DNA two dGuo adduct peaks were routinely observed with the major peak tentatively identified as (ϩ) anti-7-MBADE-trans-N 2 -dGuo. In addition, two dAdo adduct peaks were routinely observed with the major peak tentatively identified as (ϩ) anti-7-MBADE-trans-N 6 -dAdo. The tentative structural assignments are also based on our recent analysis of (Ϯ) anti-7-MBADE DNA adducts formed following reaction with calf thymus DNA (10) . Panel B of Figure 2 shows the profile of 3Ј,5Ј-diphosphodeoxyribonucleoside adducts obtained following 32 P-postlabeling analysis of an unlabeled calf thymus DNA sample that had been reacted with the (Ϯ) syn-7-MBADE. Again, reactions of this diol-epoxide with [ 3 H]dGuo-and (Ϯ) syn-dGuo adduct eluted relatively close to the major (ϩ) anti-7-MBADE-trans-N 2 -dGuo in this HPLC system and further DNA samples were isolated from mouse skin 24 h after attempts to enhance their resolution have been unsuccessful treatment with an initiating dose of 400 nmol per mouse of 7-at present.
MBA (25) . In addition to the use of HPLC for adduct separation, TLC methodology was also employed. A modified TLC procedure a Values are normalized to 400 nmol treatment dose and represent an average was established using a non-polar/polar solvent (D6) that of three to six assays.
dramatically improved the separation of (Ϯ) anti-and (Ϯ) syn-7-MBADE-DNA adducts of 7-MBA. Figure 4 shows TLC autoradiograms of the 32 P-postlabeled (Ϯ) anti-and (Ϯ) syn-7-MBADE DNA adducts formed from reaction with calf thymus DNA in vitro using both the conventional as well as the modified TLC methods. As shown in panels A and B, respectively, both the (Ϯ) anti-and (Ϯ) syn-7-MBADE-DNA adducts migrated to a similar position on chromatograms using conventional TLC analyses (22) and when mixed (panel C), they were poorly resolved. However, the use of a D6 solvent, isopropanol/4 N NH 4 OH (1:1) following D5, but in the original D3 direction, allowed significant separation of (Ϯ) anti-and (Ϯ) syn-7-MBADE-DNA adducts as shown in panels D and E, respectively, of mined by scraping each distinct spot and cochromatographing this spot with marker adducts on HPLC as shown in Figure 2 . nmol were used, respectively. The relative level of covalent Using the improved TLC procedure, a DNA sample from binding of 7-MBA to epidermal DNA was consistent with 7-MBA-treated mouse epidermis was analysed by 32 P-postits tumor initiating activity compared with the other two labeling. Representative results from this analysis are shown hydrocarbons (6.42 Ϯ 0.01 and 0.03 Ϯ 0.01, for DMBA and in Figure 5 , and revealed one major DNA adduct spot and DB[a,j]A, respectively) (25, 26) . The level of DNA binding seven minor adduct spots. Four of these DNA adduct spots with DMBA was normalized to the dose of 400 nmol to allow could be tentatively identified including the major spot (spot a direct comparison with the other two PAH. As shown in 1) as follows: spot 1, (Ϯ) anti-7-MBADE-trans-N 2 -dGuo; spot Figure 3 , topical application of 7-MBA to mouse epidermis 2(e), (ϩ) anti-7-MBADE-N 6 -dAdo(syn-7-MBADE-dAdo); in vivo led to the formation of six DNA adduct peaks detected spot 3, syn-7-MBADE-dGuo; and spot 6, syn-7-MBADEby HPLC analysis: two major and four minor DNA adduct dAdo. Notably, the other four of the DNA adduct spots found peaks. The two major DNA adduct peaks (Figure 3, peaks 4 in TLC autoradiograms of DNA samples from 7-MBA treated and 5) in DNA from mouse epidermis cochromatographed mouse epidermis did not correspond to any of the simple diolwith marker adducts formed from in vitro reactions of calf epoxide adducts derived from either the (Ϯ) anti-or (Ϯ) synthymus DNA with both (Ϯ) anti-and (Ϯ) syn-7-MBADEs 7-MBADE and therefore remain unidentified at the present (see Table II ). Further experiments utilizing other HPLC time (represented in Figure 5 as spots U1ϪU4). Based on gradients failed to resolve these two peaks to allow further autoradiographic analysis, spots 3, U1 and U3 were more clarification. In addition, attempts to separate syn-and anti-7-intense than spots 2, 6, U2 and U4 and all of these spots were MBADE-DNA adducts on immobilized boronate columns by less intense than spot 1. the procedure of Lau and Baird (27) were unsuccessful since 50% of the (Ϯ) syn-7-MBADE DNA adducts were retained on Discussion the column and eluted with (Ϯ) anti-7-MBADE-DNA adducts.
In contrast to peaks 4 and 5, HPLC peak 3 cochromatoThe present study was designed to analyze the DNA adducts formed in mouse epidermis after topical application of an graphed with a single anti-7-MBADE-dGuo adduct. Finally, a The levels of individual DNA adducts were calculated based on the average total binding level (0.373 pmol/mg of epidermal DNA) and on the percentage of radioactivity represented by each peak from HPLC chromatograms.
initiating dose (400 nmol/mouse) of 7-MBA, employing 32 Ppostlabeling followed by HPLC and TLC analyses. 7-MBA was the first carcinogenic hydrocarbon for which useful chromatographic methods for DNA adduct analyses were reported (28, 29) . These and subsequent studies indirectly suggested that the adducts formed in mouse skin in vivo were chromatographically very similar to adducts formed from 3,4-dihydrodiol-1,2-epoxide in vitro, indicating that this latter metabolite was probably responsible for the binding of the parent hydrocarbon to epidermal DNA in vivo (30) . Fluorescence spectral studies also supported this conclusion (31). The high mutagenic (32) and tumorigenic (33,34) activities found for the 3,4-dihydrodiol suggested that the 3,4-diol-1,2-epoxide was also responsible for the biological activity of 7-MBA. However, direct evidence for the formation of 7-MBADE-DNA adducts and their characteristics were lacking because a practical method of synthesizing the diastereomeric forms of this diol-epoxide was not developed until recently (9, 10) . Subsequently, characterization and two dAdo adducts, however, the binding to dGuo was MBADE-dAdo and spot 6, syn-7-MBADE-dAdo; minor adduct spots are much more extensive (9, 10) .
designated by small case letters, a-e. The origins of the chromatograms are located at the lower left hand corner. Film exposure was done with Kodak
In the present investigation, utilizing the 32 P-postlabeling X-OMAT film using intensifying screens at room temperature for 1-3 min.
assay and HPLC, chromatographic conditions were established
The adduct spots shown in parentheses in panel F indicate where minor for analyzing the marker adducts formed in the reaction of spots comigrated with major spots on the TLC chromatograms.
the racemic anti-and syn-7-MBADEs with calf thymus DNA ( Figure 1 ). From these studies, the identities of the major adducts formed by reaction of (Ϯ) anti-7-MBADE with calf thymus DNA have been tentatively assigned as derived from (ϩ) anti-7-MBADE-trans-N 2 -dGuo and (ϩ) anti-7-MBADE-trans-N 6 -dAdo (Figure 2 panel A) . These results confirm the earlier spectroscopic data showing two major peaks corresponding to (ϩ) 7-MBADE-trans-N 2 -dGuo and (ϩ) 7-MBADE-trans-N 6 -dAdo (9, 10) . The HPLC analysis of 32 P-postlabeled DNA adducts formed from the in vitro reaction with (Ϯ) syn-7-MBADE also showed binding to both dGuo and dAdo (Figure 2, panel B) .
However, further characterization of these DNA adducts has not been performed since the (Ϯ) syn-7-MBADE is very unstable and quantities of adducts sufficient for further analysis are not presently available. The major adducts formed by these two diastereomers had very similar retention characteristics when The total covalent binding of 7-MBA to epidermal DNA procedure which included the D6 solvent. The film was exposed for 24 h at was~17-fold lower than that of DMBA, and~14-fold higher Ϫ70°C. Unidentified spots were designated from U1 through U4. Numbers than that of a less potent carcinogen, DB[a,j]A (Table I) . Thus, and letters correspond to numbers and letters assigned to marker DNA adducts as shown in Figure 4 , panels DϪF.
the extent of total covalent binding to DNA was consistent with the biological activity of these three carcinogens (25, 26) . were made in this study to identify these adduct spots although the authors suggested that they may have arisen from bayUsing the HPLC approach for the analysis of 7-MBA-DNA adducts formed in vivo, we detected six DNA adduct peaks in region diol-epoxide metabolites. In our current study, we have tentatively identified four 7-MBA DNA adducts that arose HPLC chromatograms (Figure 3 ). Attempts to further resolve the HPLC peaks were unsuccessful in spite of trying various from bay-region diol-epoxide metabolites based on retention characteristics in both HPLC and TLC systems. Of particular other buffer combinations. Only one of the six peaks, i.e. peak 3 ( Figure 3 ) could be tentatively identified as single entity by interest in both Figures 3 and 5 was the presence of DNA adducts with retention characteristics different from those of HPLC (i.e. anti-7-MBADE-dGuo) (Table II) . In contrast, HPLC peaks 4 and 5 may have contained both syn-and antiadducts derived from either the anti-or syn-diol-epoxides of 7-MBA. While the nature of these DNA adducts is unknown 7-MBADE-derived dGuo/dAdo adducts (Table II) .
In order to further identify the 7-MBA-DNA adducts formed at present, metabolism studies using skin microsomes (37) or mouse skin in short-term organ culture (30) have shown that in vivo in mouse epidermis, adducts were also subjected to TLC separation applying conventional (22) , as well as, modified 7-MBA is metabolized to 7-hydroxymethyl-BA-3,4-diol as well as other diols (i.e. the 5,6-; 8,9-; and 10,11-diols). Thus, chromatographic conditions. The modified chromatographic conditions successfully separated most of the anti-and syn-7-the possibility for metabolic formation of other DNA binding intermediates clearly exists in mouse epidermis exposed to MBADE-DNA adduct markers even when they were present as a mixture compared to the conventional TLC chromato-7-MBA.
The findings in our current study are particularly interesting graphy (see again Figure 4 , panels DϪF). The presence of major and minor adduct spots on TLC chromatograms of in light of our recent studies analysing the c-Ha-ras mutations from skin tumors induced by 7-MBA (18) . In these studies, samples from reactions of (Ϯ) anti-and (Ϯ) syn-7-MBADE with calf thymus DNA were, in general, consistent with the we found that most skin papillomas initiated by 7-MBA had A 182 →T transversion mutations in codon 61 of the c-Ha-ras HPLC profiles, although the TLC method detected more spots probably due to its higher sensitivity. This combined analysis gene. These observations contrast results on the mutation spectrum obtained with (Ϯ) anti-7-MBADE in the supF gene of 7-MBA-DNA adducts in mouse epidermis revealed the presence of DNA adducts formed from the anti-7-MBA and in human Ad293 cells (19) . In this regard, the mutational spectrum of (Ϯ) anti-7-MBADE was dominated by mutations in particular the (ϩ) anti-7-MBADE (Figures 3 and 5) . The major DNA adduct, spot 1, in TLC chromatograms of epidermal at dGuo residues, primarily G→T transversions. The high proportion of tumors with A 182 →T transversion mutations in DNA samples from mice treated with 7-MBA was tentatively identified as the (ϩ) anti-7-MBADE-trans-N 2 -dGuo. This diolc-Ha-ras could be explained by the presence of dAdo adducts derived from either the syn-or anti-7-MBADE as described epoxide isomer has the (4R, 3S)-diol (2S,1R)-epoxide absolute configuration (9,10); the configuration which has been shown in the current study. In summary, the current results represent our initial studies to be the most tumorigenic of the corresponding four configurational isomers of bay-region diol-epoxides derived from attempting to characterize the adducts formed following topical application of 7-MBA to mouse epidermis. While the tentative benzo[a]pyrene, chrysene, benz[a]anthracene and B[c]Ph (35, 36) . DNA adduct spot 3 observed in TLC chromatograms identity of the major adduct and several minor adducts was established, further studies are in progress to characterize co-migrated with a syn-7-MBADE-dGuo adduct formed following reaction of this diol-epoxide with calf thymus DNA currently unidentified adducts. Nevertheless, the current studies support the hypothesis that dAdo adducts derived from bay-(see Figures 4 and 5) . Evidently these two adducts (i.e. spots 1 and 3) were eluted as a single peak (peak 4, Figure 3 ) in region diol-epoxides of 7-MBA contribute to the carcinogenicity of this PAH in mouse skin. HPLC chromatograms. The ratio of radioactivity in these two spots from thin-layer chromatograms such as that presented in Figure 5 was~3:1. Thus, peak 4 in the HPLC chromatogram
